These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15150616)

  • 1. Confounding effect of socioeconomic position in the study of height in relation to prostate cancer risk.
    Batty GD
    Br J Cancer; 2004 May; 90(9):1875; author reply 1876. PubMed ID: 15150616
    [No Abstract]   [Full Text] [Related]  

  • 2. Anthropometrics and prostate cancer risk.
    Littman AJ; White E; Kristal AR
    Am J Epidemiol; 2007 Jun; 165(11):1271-9. PubMed ID: 17395597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and the risk of prostate cancer (United States).
    Bradbury BD; Wilk JB; Kaye JA
    Cancer Causes Control; 2005 Aug; 16(6):637-41. PubMed ID: 16049801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
    Rodriguez C; Freedland SJ; Deka A; Jacobs EJ; McCullough ML; Patel AV; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):63-9. PubMed ID: 17179486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Height, urban-born and prostate cancer risk in Japanese men.
    Minami Y; Tochigi T; Kawamura S; Tateno H; Hoshi S; Nishino Y; Kuwahara M
    Jpn J Clin Oncol; 2008 Mar; 38(3):205-13. PubMed ID: 18272473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and the risk of prostate cancer.
    Porter MP; Stanford JL
    Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men.
    Bjørge T; Tretli S; Lie AK; Engeland A
    Cancer Causes Control; 2006 Sep; 17(7):983-7. PubMed ID: 16841265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years.
    Lund Håheim L; Wisløff TF; Holme I; Nafstad P
    Am J Epidemiol; 2006 Oct; 164(8):769-74. PubMed ID: 16952929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of adult body mass index and height with anxiety, depression, and suicide in the general population: the HUNT study.
    Bjerkeset O; Romundstad P; Evans J; Gunnell D
    Am J Epidemiol; 2008 Jan; 167(2):193-202. PubMed ID: 17981889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women.
    Engeland A; Tretli S; Austad G; Bjørge T
    Cancer Causes Control; 2005 Oct; 16(8):987-96. PubMed ID: 16132807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass and physical activity and risk of gastric cancer in a population-based cohort study in Norway.
    Sjödahl K; Jia C; Vatten L; Nilsen T; Hveem K; Lagergren J
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):135-40. PubMed ID: 18187390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men.
    Kurahashi N; Iwasaki M; Sasazuki S; Otani T; Inoue M; Tsugane S
    Br J Cancer; 2006 Mar; 94(5):740-2. PubMed ID: 16465189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
    Gong Z; Neuhouser ML; Goodman PJ; Albanes D; Chi C; Hsing AW; Lippman SM; Platz EA; Pollak MN; Thompson IM; Kristal AR
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1977-83. PubMed ID: 17035408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer.
    Ochiai A; Fritsche HA; Babaian RJ
    Urology; 2005 Oct; 66(4):819-23. PubMed ID: 16230145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
    Freedland SJ; Terris MK; Platz EA; Presti JC
    Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical history, sexual, and maturational factors and prostate cancer risk.
    Lightfoot N; Conlon M; Kreiger N; Sass-Kortsak A; Purdham J; Darlington G
    Ann Epidemiol; 2004 Oct; 14(9):655-62. PubMed ID: 15380796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and the risk of prostate cancer in Italy.
    Tavani A; Gallus S; Bertuzzi M; Dal Maso L; Zucchetto A; Negri E; Franceschi S; Ramazzotti V; Montella M; La Vecchia C
    Eur Urol; 2005 Mar; 47(3):313-7; discussion 317. PubMed ID: 15716192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study.
    Laukkanen JA; Laaksonen DE; Niskanen L; Pukkala E; Hakkarainen A; Salonen JT
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1646-50. PubMed ID: 15466982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.